Community-associated staphylococcus aureus infections in children

Expert Review of Anti-Infective Therapy

Volumn 8, Issue 5, 2010, Pages 541-554

  Rojo, Pablo ^a   Barrios, Marta ^a   Palacios, Alba ^a   Gomez, Carmen ^a   Chaves, Fernando ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Children; Clindamycin; Cloxacillin; Community associated methicillin resistant Staphylococcus aureus; Community associated methicillin susceptible Staphylococcus aureus; Community associated Staphylococcus aureus; Panton Valentine leukocidin; Treatment

Indexed keywords

BETA LACTAM ANTIBIOTIC; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; IMMUNOGLOBULIN; LINEZOLID; METICILLIN; NAFCILLIN; OXACILLIN; PANTON VALENTINE LEUKOCIDIN; RIFAMPICIN; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERIAL ARTHRITIS; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; COMMUNITY; COMMUNITY ACQUIRED PNEUMONIA; COMMUNITY ASSOCIATED STAPHYLOCOCCUS AUREUS INFECTION; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DRUG EFFICACY; HEAD AND NECK INFECTION; HUMAN; INCIDENCE; INTESTINE INFECTION; LUNG DISEASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEWBORN INFECTION; OSTEOMYELITIS; PNEUMONIA; PREVALENCE; PYOMYOSITIS; REVIEW; SEPSIS; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; EXOTOXINS; HUMANS; INFANT; LEUKOCIDINS; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 77952265098     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.34     Document Type: Review

References (126)

1. Ogston A. Report upon micro-organisms in surgical diseases. Br. Med. J. 1, 369-375 (1881).
2. Kaplan SL, Hulten KG, Gonzalez BE et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin. Infect. Dis. 40, 1785-1791 (2005).
3. Gerber JS, Coffin SE, Smathers SA, Zaoutis TE. Trends in the incidence of methicillin-reistant Staphylococcus aureus infection in children's hospitals in the United States. Clin. Infect. Dis. 49, 65-71 (2009).
4. Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg. Infect. Dis. 13, 236-242 (2007).
5. Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J. Hosp. Infect. 25, 97-108 (1993).
6. Kowalski TJ, Berbari EF, Osmon DR. Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clin. Proc. 80, 1201-1208 (2005).
7. Marcinak JF, Frank AL. Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children. Expert. Rev. Anti Infect. Ther. 4(1), 91-100 (2006).
8. Crawford SE, Daum RS. Epidemic community-associated methicillin resistant Staphylococcus aureus. Pediatr. Infect. Dis. J. 24, 459-460 (2005).
9. Dietrich DW, Auld DB, Mermel LA. Community-acquired methicillin-resistant Staphylococcus aureus in southeastern New England. Pediatrics 113, e347-e352 (2004).
10. Buckingham SC, MCDougal LK, Cathey LD et al. Emergence of community-associate methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital. Pediatr. Infect. Dis. J. 23, 619-624 (2004).
11. Chen AE, Goldstein M, Carroll K et al. Evolving epidemiology of pediatric Staphylococcus aureus cutaneous infections in a Baltimore hospital. Pediatr. Emerg. Care. 22(10), 717-723 (2006).
12. Centers for Disease control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. MMWR Morb. Mortal. Wkly Rep. 48, 707-710 (1999).
13. Klevens RM, Morrison MA, Nadle J et al. Invasive methicillin-resistant Staphylococcus aureus infections in the USA. JAMA 298, 1763-1771 (2007).
14. Kluytmans-Vanden Bergh MFQ, Kluytmans AJW. Communty-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clin. Microbiol. Infect. 12(1), 9-15 (2006).
15. Vandenesch F, Naimi T, Enright MC et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton- Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 9, 978-983 (2003).
16. Niniou I, Vourli S, Lebessi E et al. Clinical and molecular epidemiology of community-acquired, methicillin-resistant Staphylococcus aureus infections in children in central Greece. Eur. J. Clin. Microbiol. Infect. Dis. 27(9), 831-837 (2008).
17. Elston JW, Barlow GD. Community-associated MRSA in the United Kingdom. J. Infect. 59 (3), 149-155 (2009).
18. Daskalaki M, Rojo P, Marin-Ferrer M et al. Panton-Valentine leukocidin-positive Staphylococcus aureus skin and soft tissue infections among children in an emergency department in Madrid, Spain. Clin. Microbiol. Infect. 16(1), 74-77 (2010).
19. Broseta A, Chaves F, Rojo P et al. Emergence of a single clone of community-associated methicillin-resistant Staphylococcus aureus in southern Madrid children. Enferm. Infecc. Microbiol. Clin. 24(1), 31-35 (2006).
20. Paganini H, Della MP, Muller B et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in children: multicenter trial. Arch. Argent. Pediatr. 106(5), 397-403 (2008).
21. Nimmo GR, Coombs GW. Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia. Int. J. Antimicrob. Agents 31(5), 401-410 (2008).
22. Chen CJ, Huang YC, Chiu CH, Su LH, Lin TY. Clinical features and genotyping analysis of community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwanese children. Pediatr. Infect. Dis J. 24, 40-45 (2005).
23. Reyes J, Rincon S, Diaz L et al. Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America. Clin. Infect. Dis. 15(49), 1861-1867 (2009).
24. Deurenberg RH, Stobberingh EE. The evolution of Staphylococcus aureus. Infect. Genet. Evol. 8, 747-763 (2008).
25. Purcell K, Fergie J. Epidemic of community-acquired methicillin resistant Staphylococcus aureus infections : a 14 year study at Driscoll Childreńs Hospital. Arch. Pediatr. Adolesc. Med. 159, 980-985 (2005).
26. Miller LG, Perdreau-Remington F, Bayer AS et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin- susceptible S. aureus infection: a prospective investigation. Clin. Infect. Dis. 44, 471-482 (2007).
27. Gorwitz RJ. A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr. Infect. Dis. J. 27, 1-7 (2008).
28. Sattler CA, Mason EO, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infections in children. Pediatr. Infect. Dis. J. 21, 910-917 (2002).
29. Swanson DL. Vetter RS. Bites of brown recluse spiders and suspected necrotic arachnidism. N. Engl. J. Med. 352, 700-707 (2005).
30. Miller LG, Quan C, Shay A et al. A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clin. Infect. Dis. 44, 483-492 (2007).
31. Moran GJ, Krishnadasan A, Gorwitz RJ et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355, 666-674 (2006).
32. Lina G, Piemont Y, Godail-Gamot F et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29, 1128-1132 (1999).
33. Tinelli M, Monaco M, Vimercati M et al. Methicillin-susceptible Staphylococcus aureus in skin and soft tissue infections, in northern Italy. Emerg. Infect. Dis. 15(2), 250-257 (2009).
34. Boubaker K, Diebold P, Blanc DS et al. Panton-Valentine leukocidin and staphyloccoccal skin infection in schoolchildren. Emerg. Infect. Dis. 10, 121-124 (2004).
35. Orscheln RC, Hunstad DA, Fritz SA et al. Contribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections. Clin. Infect. Dis. 49, 536-542 (2009).
36. Giudice P, Blanc V, Rougemont A et al. Primary skin abscesses are mainly caused by Panton-Valentine leukocidin-positive Staphylococcus aureus strains. Dermatology 219(4), 299-302 (2009).
37. Martinez-Aguilar G, Avalos-Mishaan A, Hulten K et al. Community-acquired methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr. Infect. Dis. J. 23, 701-706 (2004).
38. Arnold SR, Elias D, Buckingham SC et al. Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus. J. Pediatr. Orthop. 26, 703-708 (2006).
39. Bocchini CE, Hulten KG, Mason EO et al. Panton-Valentine leukocidin genes are associated with enhaced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomielitis in children. Pediatrics 117(2), 433-440 (2006).
40. Dohin B, Gillet Y, Kohler R et al. Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus. Pediatr. Infect. Dis. J. 26, 1042-1048 (2007).
41. Cremieux AC, Dumitrescu O, Lina G et al. Panton-Valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomielitis. PloS One 4(9), e7204 (2009).
42. Pannaraj PS, Hulten KG, Gonzalez BE et al. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin. Infect. Dis. 43(8), 953-960 (2006).
43. Tobeña M, Coll F, García C et al. Necrotizing fasciitis due to community-acquired Panton-Valentine leukocidin methicillin-resistant Staphylococcus aureus. Ann. Pediatr. (Barc.). 70(4), 374-378 (2009).
44. Gerard D, Mariani-Kurkdjian P, Sachs P et al. Facial necrotizing fasciitis in an infant caused by a five toxin-secreting methicillin-susceptible Staphylococcus aureus. Intensive Care Med. 53(6), 1445-11146 (2009).
45. Wright CT, Stocks RM, Armstrong DL, Arnold SR, Gould HJ. Pediatric mediastinitis as a complication of methicillin-resistant Staphylococcus aureus retropharyngeal abscess. Arch. Otolaryngol. Head. Neck. Surg. 134(4), 408-413 (2008).
46. Brook I. Recovery of methicillin-resistant Staphylococcus aureus from a child with acute otitis media. Pediatr. Infect. Dis. J. 27, 372-373 (2008).
47. Brook I, Foote PA, Hausfeld JN. Increase in the frequency of recovery of methicillin-resistant Staphylococcus aureus in acute and chronic maxillary sinusitis. J. Med. Microbiol. 57(8), 1015-1017 (2008).
48. Goldstein SM, Shelsta HN. Community-acquired methicillin-resistant Staphylococcus aureus periorbital cellulitis: a problem here to stay. Ophthal. Plast. Reconstr. Surg. 25(1), 77 (2009).
49. Barril MF, Ferolla FM, Jose P et al. Nasal septal abscess. Arch. Argent. Pediatr. 106(6), 538-541 (2008).
50. Agwu A, Brady KM, Ross T et al. Cholera-like diarrhea and shock associated with community-acquired methicillin-resistant Staphylococcus aureus (USA400 clone) pneumonia. Pediatr. Infect. Dis. J. 26(3), 271-273 (2007).
51. Gonzalez BE, Kaplan SL. Severe staphylococcal infections in children. Pediatr. Ann. 37(10), 686-693 (2009).
52. Shulman ST, Ayoub EM. Severe staphylococcal sepsis in adolescents. Pediatrics 58(1), 59-66 (1976).
53. Cunnington A, Brick T, Cooper M et al. Severe invasive Panton-Valentine leucocidin positive Staphylococcus aureus infections in children in London, UK. J. Infect. 59(1), 28-36 (2009).
54. Gonzalez BE, Martinez-Aguilar G, Hulten KG et al. Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 115(3), 642-648 (2005).
55. Tseng MH, Wei BH, Lin WJ et al. Fatal sepsis and necrotizing pneumonia in a child due to community-acquired methicillin-resistant Staphylococcus aureus: case report and literature review. Scand. J. Infect. Dis. 37(6-7), 504-507 (2005).
56. Adem PV, Montgomery CP, Husain AN et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N. Engl. J. Med. 353, 1245-1251 (2005).
57. Peleg AY, Munckhof WJ, Kleinschmidt SL, Stephens AJ, Huygens F. Life-threatening community-acquired methicillin-resistant Staphylococcus aureus infection in Australia. Eur. J. Clin. Microbiol. Infect. Dis. 24(6), 384-387 (2005).
58. Rozenbaum R, Sampaio MG, Batista GS et al. The first report in Brazil of severe infection caused by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). Braz. J. Med. Biol. Res. 42(8), 756-760 (2009).
59. Rougemont AL, Buteau C, Ovetchkine P, Bergeron C, Fournet JC, Soglio DB. Fatal cases of Staphylococcus aureus pleural empyema in infants. Pediatr. Dev. Pathol. 12(5), 390-393 (2009).
60. Castaldo ET, Yang EY. Severe sepsis attributable to community-associated methicillin-resistant Staphylococcus aureus: an emerging fatal problem. Am. Surg. 73, 684-687 (2007).
61. Reed C, Kallen AJ, Patton M et al. Infection with community-onset Staphylococcus aureus and influenza virus in hospitalized children. Pediatr. Infect. Dis. J. 28(7), 572-576 (2009).
62. Creel AM, Durham SH, Benner KW et al. Severe invasive community-associated methicillin-resistant Staphylococcus aureus infections in previously healthy children. Pediatr. Crit. Care Med. 10(3), 323-327 (2009).
63. Kravitz GR, Dries DJ, Peterson ML et al. Purpura fulminans due to Staphylococcus aureus. Clin. Infect Dis. 40, 941-947 (2005).
64. Hussain A, Robinson G, Malkin J et al. Purpura fulminans in a child secondary to Panton-Valentine leukocidin-producing Staphylococcus aureus. J. Med. Microbiol. 56, 1407-1409 (2007).
65. Gonzalez BE, Hulten KG, Dishop MK et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin. Infect. Dis. 41(5), 583-590 (2005).
66. Schultz KD, Fan LL, Pinsky J et al. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 113, 1735-1740 (2004).
67. Hageman JC, Uyeki TM, Fancis JS et al. Severe community-acquired pneumonia due to Staphylococcus aureus 2003-2004 influenza season. Emerg. Infect. Dis. 12(6), 894-899 (2006).
68. Gillet Y, Issartel B, Vanhems P et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359(9308), 753-759 (2002).
69. Gillet Y, Vanhems P, Lina G et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Stahphylococcus aureus containg Panton- Valentine leukocidin. Clin. Infect. Dis. 45, 315-321 (2007).
70. Barrios M, Alcolea A, Negreira S et al. Necrotizing pneumonia due to community-acquired methicillin resistant Staphylococcus aureus in a pediatric patient. Enferm. Infecc. Microb. Clin. 26(6), 398-399 (2008).
71. Thomas B, Pugalenthi A, Chilvers M. Pleuropulmonary complications of PVL-positive Staphylococcus aureus infection in children. Act. Paed. 98, 1372-1375 (2009).
72. Voyich JM, Otto M, Mathema B et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Sataphylococcus aureus disease? J. Infect. Dis. 194, 1761-1770 (2006).
73. Labandeira-Rey M, Couzon F, Boisset S et al. Staphylococcus aureus Panton- Valentine leukocidine causes necrotizing pneumonia. Science 315(5815), 1130-1133 (2007).
74. Bentzmann S, Tristan A, Etienne J et al. Staphylococcus aureus isolates associated with necrotizing pneumonia bind to basement membrane type I and IV collagens and laminin. J. Infect. Dis. 190, 1506-1515 (2004).
75. Cheng V, Lau YK, Lee KL et al. Fatal co-infection with swine origin influenza virus A/H1N1 and community-acquired methicillin-resistant Staphylococcus aureus. J. Infect. 59, 366-370 (2009).
76. Gorenstein A, Gross E, Houri S et al. The pivotal role of deep vein thrombophlebitis in the development of acute disseminated staphylococcal disease in children. Pediatrics 106(6), e87 (2000).
77. Miles F, Voss L, Segedin E, Anderson BJ. Review of Staphylococcus aureus infections requiring admission to a pediatric intensive care unit. Arch. Dis. Child. 90(12), 1274-1278 (2005).
78. Horvath FL, Brodeur AE, Cherry JD. Deep thrombophlebitis associated with acute osteomyelitis. J. Pediatr. 79, 815-818 (1971).
79. Crary SE, Buchanan GR, Drake CE et al. Venous thrombosis and thromboembolism in children with osteomyelitis. J. Pediatr. 149(4), 537-541 (2006).
80. Hollmig ST, Copley LA, Browne RH et al. Deep venous thrombosis associated with osteomyelitis in children. J. Bone. Joint. Surg. Am. 89(7), 1517-1523 (2007).
81. Gonzalez BE, Teruya J, Mahoney DH et al. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics 117(5), 1673-1679 (2006).
82. Fortunov R, Hulten KG, Hammerman WA et al. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics 118(3), 874-881 (2006).
83. Fortunov RM, Hulten KG, Hammerman WA et al. Evaluation and treatment of community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics 120(5), 937-945 (2007).
84. Tinelli M, Monaco M, Vimercati M et al. Methicillin-susceptible Staphylococcus aureus in skin and soft tissue infections, in northern Italy. Emerg. Infect. Dis. 15(2), 250-257 (2009).
85. McCaskill ML, Mason EO, Kaplan SL, Hammerman W, Lamberth LB, Hulten KG. Increase of the USA300 clone among comunity-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections. Pediatr. Infect. Dis. J. 26, 1122-1227 (2007).
86. Diep BA, Carleton HA, Chang RF, Sensabaugh GF, Perdreau-Remington F. Roles of 34 virulence genes in the evolution of hospital and community-associated strains of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 193, 1495-1503 (2006).
87. Diep BA, Stone GG, Basuino L et al. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA 300 clone of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 197, 1523-1530 (2008).
88. Montgomery CP, Boyle-Vavra S, Daum RS. The arginine catabolic mobile element (ACME) is not associated with enhanced virulence in experimental invasive disease caused by the community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) genetic background USA 300. Infect. Inmmun. 77, 2650-2656 (2009).
89. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O. Poring over pores: a-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat. Med. 13, 1405-1406 (2007).
90. Bartlett AH, Foster TJ, Hayashida A, Park PW. A-toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia. J. Infect. Dis. 198, 1529-1535 (2008).
91. Wang R, Braughton KR, Kretschmer D et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 13, 1510-1514 (2007).
92. Gillet Y, Etienne J, Lina G, Vandenesch F. Association of necrotizing pneumonia with Panton-Valentine leukocidin-producing Staphylococcus aureus, regardless of methicillin resistance. Clin. Infect. Dis. 47, 985-986 (2008).
93. Lee MC, Rios AM, Fonseca M et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr. Infect. Dis. J. 23, 123-127 (2004).
94. Tien I. Update on the management of skin, soft tissue, and osteoarticular infections in children. Curr. Opin. Pediatr. 18, 254-259 (2006).
95. Elliot DJ, Zaoutis TE, Troxel AB, Loh A, Karen R. Empiric antimicrobial therapy for pediatric skin and soft tissue infections in the era of methicillin-resistant Staphylococcus aureus. Pediatrics 123, e959-e966 (2009).
96. Gillet Y, Dohin B, Dumitrescu O et al. Osteoarticular infections with Staphylococcus aureus secreting Panton-Valentine leukocidin. Arch. Pediatr. 14, S102-S107 (2007). (Pubitemid 47589104)
97. Dumitrescu O, Badiou C, Bes M et al. Effects of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain. Clin. Microbiol Infect. 14, 384-388 (2008).
98. Dumitrescu O, Boisset S, Badiou C et al. Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin. Antimicrob. Agents Chemother. 51, 1515-1519 (2007). (Pubitemid 46586841)
99. Martinez-Aguilar G, Hammerman WA, Mason EO, Kaplan SL. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr. Infect. Dis. J. 22, 593-598 (2003).
100. Braun L, Craft D, Williams R, Tuamokumo F, Otolini M. Increasing clindamicyn resistance among methicillin-resistant Staphylococcus aureus in 57 northeast United States military treatment facilities. Pediatr. Infect. Dis. J. 24, 622-626 (2005).
101. Frank AL, Marcinak JF, Mangat PD et al. Clindamycin treatment of methicillin-ressitant Staphylococcus aureus infections in children. Pediatr. Infect. Dis. J. 21, 530-534 (2002).
102. Saphyakhajon P, Joshi AY, Huskins WC, Henry NK, Boyce TG. Empiric antibiotic therapy for acute osteoarticular infections with suspected methicillin-resistant Staphylococcus aureus or Kingella. Pediatr. Infect. Dis. J. 27, 765-767 (2008).
103. Rana B, Butcher I, Grigoris P, Murnaghan C, Seaton RA, Tobin CM. Linezolid penetration into osteo-articular tissues. J. Antimicrob. Chemother. 50, 747-750 (2002).
104. Chen CJ, Chiu CH, Lin TY, Lee ZL, Yang WE, Huang YC. Experience with linezolid therapy in children with osteoarticular infections. Pediatr. Infect. Dis. J. 26, 985-988 (2007).
105. Kaplan SL. Use of linezolid in children. Pediatr. Infect. Dis. J. 21, 870-872 (2002).
106. Etienne J, Dumitrescu O. Panton- Valentine leucocidin associated Staphylococcus aureus infections. BMJ 339, b4083 (2009).
107. Baker CJ, Frenck RW. Change in management of skin/soft tissue infections needed. AAP News 25, 105-117 (2004).
108. Hidron AI, Low CE, Honig EG, Blumberg HM. Emergence of community-acquired methicillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotizing community-onset pneumonia. Lancet Infect. Dis. 9, 384-392 (2009).
109. Fergie J, Purcell K. The treatment of community-acquired methicillin-resistant Staphylococcus aureus infections. Pediatr. Infect. Dis. J. 27, 67-68 (2008).
110. Nathwani D, Morgan M, Masterton RG. Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J. Antimicrob. Chemother. 61, 976-994 (2008).
111. Micek ST, Dunne M, Kollef MH. Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus. Chest 128, 2732-2738 (2005).
112. Gomez J, Garcia-Vazquez E, Baños R et al. Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: the role of empiric antibiotic therapy. Eur. J. Clin. Microbiol. Infect. Dis. 26, 239-245 (2007).
113. Ellis MW, Lewis JS. Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections. Curr. Opin. Infect. Dis. 18, 496-501 (2005).
114. Bliziotis IA, Ntziora F, Lawrence KR, Falagas ME. Rifampin as adjuvant treatment of Gram-positive bacterial infections: a systematic review of comparative clinical trials. Eur. J. Clin. Microbiol. Infect. Dis. 26, 849-856 (2007).
115. Gauduchon V, Cozon G, Vandenesch F et al. Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J. Infect Dis. 189, 346-353 (2004).
116. Croze M, Dauwalder O, Dumitrescu O et al. Serum antibodies against Panton- Valentine leukocidin in a normal population and during Staphylococcus aureus infection. Clin. Microbiol. Infect. 15, 144-148 (2009).
117. Brown EL, Bowden MG, Bryson RS et al. Pediatric antibody response to community-acquired Staphylococcus aureus infection is directed to Panton-Valentine leukocidin. Clin. Vaccine Immunol. 16, 139-141 (2009).
118. Hampson FG, Hancock SW, Primhak RA. Diseminated sepsis due to a Panton-Valentine leukocidin producing strain of community acquired methicillin resistant Staphylococcus aureus and use of intravenous immunoglobulin therapy. Arch. Dis. Child. 91, 201 (2006).
119. Libert N, Borne M, Janvier F et al. Successful treatment of life-threatening Panton-Valentine leucocidin positive Staphylococcus aureus pneumonia with antibiotics and immunoglobulins targeting the toxin production. Rev. Med. Interne 30(10), 907-910 (2009).
120. Salliot C, Zeller V, Puechal X et al. Panton-Valentine leukocidin-producing Staphylococcus aureus infections: report of 4 French cases. Scan. J. Infect. Dis. 38, 192-195 (2006).
121. Bradley JS. Newer antistaphylococcal agents. Curr. Opin. Pediatr. 17, 71-77 (2005).
122. Carpenter CF, Chambers HF. Daptomycin: another novel agent for treating infections due to drug-resistant Gram-positive pathogens. Clin. Infect. Dis. 38, 994-1000 (2004).
123. Ardura MI, Mejias A, Katz KS, Revell P, McCracken GH, Sanchez PJ. Daptomycin therapy for invasive Gram-positive bacterial infections in children. Pediatr. Infect. Dis. J. 26, 1128-1132 (2007).
124. Abdel-Rahman SM, Benziger DP, Jacobs RF, Jafri HS, Hong EF, Kearns GL. Single-dose pharmacokinetics of Daptomycin in children with suspected or proved Gram-positive infections. Pediatr. Infect. Dis. J. 27, 330-334 (2008).
125. Loeffler AM, Drew RH, Perfect JR et al. Safety and efficacy of quinupristin/ dalfopristin for treatment of invasive Gram-positive infections in pediatric patients. Pediatr. Infect. Dis. J. 21, 950-956 (2002).
126. Ragle BE, Bubeck J. Anti-a-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect. Immun. 77, 2712-11718 (2009).